Related Experiment Video
Updated: Dec 26, 2025

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Current Knowledge and Attitudes Concerning Cost-Effectiveness in Glaucoma Pharmacotherapy: A Glaucoma Specialists
Robert M Feldman1, George A Cioffi2, Jeffrey M Liebmann3
1The University of Texas Medical School Houston, TX, USA.
Glaucoma specialists understand treatment costs but need more data for cost-effectiveness decisions. Newer therapies may improve cost-effectiveness by balancing efficacy, adherence, and side effects.
Area of Science:
- Ophthalmology
- Health Economics
- Pharmacoeconomics
Background:
- Healthcare costs necessitate cost-reduction strategies.
- Open-angle glaucoma (OAG) presents significant direct and indirect costs.
- Understanding cost-effectiveness of intraocular pressure (IOP)-lowering treatments is crucial for clinicians.
Purpose of the Study:
- Explore clinician attitudes on glaucoma therapy costs and cost drivers.
- Assess perspectives on implementing cost-effectiveness decisions in glaucoma care.
- Evaluate the clinical utility and cost-effectiveness of available glaucoma treatments.
Main Methods:
- Pilot focus group study with six US glaucoma specialists.
- Two teleconferencing sessions, each with three participants.
- Moderated discussion guided by a structured guide after reviewing 25 health economics publications.
Main Results:
- Clinicians recognize key cost drivers: medications, diagnostics, visits, and treatment changes.
- Cost-effectiveness is viewed as appropriate for decision-making, but more data is needed.
- Existing studies lack comprehensive patient-centered data (quality of life, adherence) and longitudinal analysis.
Conclusions:
- Clinicians find cost-effectiveness data appropriate for treatment decisions.
- Newer IOP-lowering therapies may enhance cost-effectiveness through improved efficacy, adherence, and side-effect profiles.
- Future research should incorporate clinician perspectives, real-world data, long-term outcomes, and minimize bias.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Angle Closure Glaucoma: Treatment
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

